Eli Lilly and Company (LLY) Stock Price
$770.6 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
7 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Eli Lilly and Company, AI stock picks, stock alerts and much more.
LLY AI Stock Analysis
Financial Performance
Eli Lilly and Company's recent financial performance shows a positive trend. The company reported revenue of $11.4B, up by 1.2% from the previous quarter and up by a significant 22.3% year over year. Their gross profit was $9.3B, also showing an increase both quarterly (1.5%) and annually (20.5%). Operating income profit was $4.4B, which is a substantial increase of 44.1% YoY and a moderate increase of 3% QoQ.
The EBITDA ratio at 0.2 indicates that the company has been generating healthy profits.
Stock Price
The stock price currently stands at $761.58, experiencing a decline of -3.5% over the last month but still significantly higher than its 200-day moving average of $839.06 which suggests potential undervaluation in the short term.
The RSI value at around 32 indicates that the stock may be oversold and can potentially rebound.
Alternative Data Signals
A look at alternative data signals reveals encouraging trends for Eli Lilly and Company's business prospects: Web traffic is growing substantially MoM (+20%) as well as YoY (+64%), reflecting increased online interest in the company; Job postings remain stable indicating steady growth; Employee outlook is highly positive with an estimated score of 83%, although slightly down YoY (-1%). Social media following across Twitter, Instagram, and Facebook are all on an upward trend reflecting growing public engagement with their brand.
Conclusion
In conclusion, despite some short-term volatility in stock price, Eli Lilly shows strong fundamentals in terms of its revenue growth, profitability and positive alternative data signals. Therefore, the outlook for Eli Lilly's stock performance is bullish.
Note: This AI Stock Analysis is based on data as of January 23. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Eli Lilly and Company (LLY) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Eli Lilly and Company (LLY), currently trading at $770.6, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About LLY
-
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide.
-
Symbol
LLY
-
Market
NYSE
-
Industry
Drug Manufacturers - General
-
Market Cap
730.4B
Similar Stocks
 |
Johnson & Johnson JNJ |
$151.3 1% |
5 |
 |
Pfizer PFE |
$24.03 0.3% |
4 |
 |
AbbVie ABBV |
$183.8 0.8% |
5 |
 |
Merck & Company MRK |
$80.16 1.4% |
5 |
 |
Novartis NVS |
$117.5 1.5% |
6 |
News
LLY Alternative Data
Web Traffic
Eli Lilly and Company receives an estimated 4.9M monthly visitors to lilly.com.
-
Web Traffic
4857914
-
Change from Previous Month
0.9%
-
3 Month Change
1%
-
YoY Change
1%
Twitter Followers
Eli Lilly and Company has 142,650 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.2% over the last month.
-
Twitter Followers
142650
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Facebook Engagement
Eli Lilly and Company has engaged 5,805 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
5805
-
Daily Change
10.2%
-
1 Month Change
14.4%
-
3 Month Change
102.5%
-
YoY Change
102.5%
Instagram Followers
Eli Lilly and Company has 0 Instagram Followers on its main Instagram account, down by -100% over the last month.
-
Instagram Followers
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Followers
2,107,635 are following Eli Lilly and Company on LinkedIn, up by 1.1% over the last month.
-
LinkedIn Followers
2107635
-
Daily Change
0.1%
-
1 Month Change
1.1%
-
3 Month Change
4.2%
Job Postings
Eli Lilly and Company currenly has an estimated 1,000 open job postings.
-
Job Postings
1000
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Eli Lilly and Company has 50,564 employees, up by 1.7% over the last month.
-
LinkedIn Employees
50564
-
Daily Change
0.2%
-
1 Month Change
1.7%
-
3 Month Change
4.3%
-
YoY Change
4.3%
Reddit Mentions
Eli Lilly and Company has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
-
1 Month Change
80%
-
3 Month Change
50%
Reddit Sentiment
The sentiment Score for Eli Lilly and Company is 90 out of 100, which represents a bullish sentiment.
-
Reddit Sentiment
89.8333
-
Daily Change
35.1%
-
1 Month Change
94.4%
Business Outlook
According to employee reviews, the business outlook among employees at Eli Lilly and Company is 85 out of 100 (very bullish).
-
Business Outlook
85
-
Change from Previous Month
0%
-
3 Month Change
1.2%
-
YoY Change
1.2%
News Mentions
Eli Lilly and Company was mentioned 14 times in the news yesterday.
-
News Mentions
14
-
Daily Change
33.3%
-
1 Month Change
0%
-
3 Month Change
600%
LLY Financials
LLY Key Metrics
-
Total Revenue
$12.7B
-
Net Income
$2.8B
-
Earnings per Share
$3.07
-
Free cash flow
$156.1M
-
EBITDA
$4.2B
-
EBITDA Ratio
0.32703
-
Total Assets
$89.4B
LLY 2-year Revenue & Income
LLY 2-year Free Cash Flow
LLY Technicals
LLY SMA
LLY RSI
FAQ
What's the current price of Eli Lilly and Company (LLY) Stock?
The price of an Eli Lilly and Company (LLY) share is $770.6.
What's the market cap of Eli Lilly and Company?
The current market cap of Eli Lilly and Company is 730.4B.
Should I buy or sell LLY?
Eli Lilly and Company shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Eli Lilly and Company is better viewed as a hold or accumulate position while waiting for further developments.
Is Eli Lilly and Company a good investment?
The current analysis of Eli Lilly and Company's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Eli Lilly and Company's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Eli Lilly and Company (LLY) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Eli Lilly and Company stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Eli Lilly and Company (LLY) that investors often compare it to?
Eli Lilly and Company (LLY) is often compared to similar stocks such as Johnson & Johnson, Pfizer, AbbVie, Merck & Company and Novartis.
What is the forecast for Eli Lilly and Company's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Eli Lilly and Company's stock price to be around $808.1 in 2026. Starting from the current price of $770.6, this represents a 4.9% change in price, indicating a neutral outlook for the stock.
How to buy Eli Lilly and Company (LLY) Stock?
Eli Lilly and Company stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Eli Lilly and Company shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.